Pages that link to "Q21034080"
Jump to navigation
Jump to search
The following pages link to Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration (Q21034080):
Displaying 50 items.
- Pre-referral rectal artesunate for severe malaria (Q24194527) (← links)
- Pre-referral rectal artesunate for severe malaria (Q24202504) (← links)
- Recent advances in malaria drug discovery (Q27010534) (← links)
- Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review (Q28109657) (← links)
- Anticancer properties of distinct antimalarial drug classes (Q28538116) (← links)
- Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria. (Q30867699) (← links)
- Malaria in children (Q33404647) (← links)
- Correct dosing of artemether-lumefantrine for management of uncomplicated malaria in rural Tanzania: do facility and patient characteristics matter? (Q33645108) (← links)
- Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteers (Q33719587) (← links)
- A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance (Q33761137) (← links)
- Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models. (Q34318516) (← links)
- CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide (Q34437996) (← links)
- pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members (Q34630304) (← links)
- The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine (Q34694931) (← links)
- Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects (Q34922652) (← links)
- Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges (Q34953705) (← links)
- Efficacy of intranasal administration of artesunate in experimental cerebral malaria (Q35060339) (← links)
- Quantitative analysis of cepharanthine in plasma based on semiautomatic microextraction by packed sorbent combined with liquid chromatography (Q35137898) (← links)
- Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells (Q35741661) (← links)
- Stability of the antimalarial drug dihydroartemisinin under physiologically relevant conditions: implications for clinical treatment and pharmacokinetic and in vitro assays (Q35746141) (← links)
- Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers (Q35771822) (← links)
- Advances in the treatment of malaria (Q36404786) (← links)
- Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial (Q36427654) (← links)
- Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread (Q36722524) (← links)
- Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen (Q36778732) (← links)
- Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs (Q36916456) (← links)
- Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers (Q37193141) (← links)
- Pharmacokinetics, metabolism, and in vivo efficacy of the antimalarial natural product bromophycolide A (Q37244996) (← links)
- Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling (Q37327771) (← links)
- Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients (Q37335755) (← links)
- Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis (Q37699414) (← links)
- Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum (Q37712176) (← links)
- Plasmodium falciparum gametocytes: with a view to a kill. (Q38129536) (← links)
- Synthesis of five- and six-membered cyclic organic peroxides: Key transformations into peroxide ring-retaining products (Q38181092) (← links)
- Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods (Q38627882) (← links)
- Antimalarial activity of kinase inhibitor, nilotinib, in vitro and in vivo (Q38908654) (← links)
- Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells. (Q38962966) (← links)
- Design of Drug Delivery Systems Containing Artemisinin and Its Derivatives. (Q39147907) (← links)
- Highly active ozonides selected against drug resistant malaria (Q39186592) (← links)
- Methylene Homologues of Artemisone: An Unexpected Structure-Activity Relationship and a Possible Implication for the Design of C10-Substituted Artemisinins (Q39702161) (← links)
- Virtual-screening workflow tutorials and prospective results from the Teach-Discover-Treat competition 2014 against malaria (Q41588963) (← links)
- Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model (Q41695336) (← links)
- Antiviral effects of artesunate on polyomavirus BK replication in primary human kidney cells (Q41907468) (← links)
- Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives. (Q42272265) (← links)
- Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells (Q42430876) (← links)
- Is there a differential conversion of artesunate to dihydroartemisinin in pregnant vs. post-partum patients with malaria after oral artesunate dosing? (Q42878794) (← links)
- Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer. (Q44872854) (← links)
- Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs-Implication for Herb-Drug Interaction. (Q46260895) (← links)
- Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model (Q47865052) (← links)
- Development of sensitive direct chemiluminescent enzyme immunoassay for the determination of dihydroartemisinin in plasma (Q47925010) (← links)